1. Home
  2. MLSS vs LTRN Comparison

MLSS vs LTRN Comparison

Compare MLSS & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.33

Market Cap

22.1M

Sector

Health Care

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$2.15

Market Cap

22.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLSS
LTRN
Founded
1989
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1M
22.2M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
MLSS
LTRN
Price
$0.33
$2.15
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
1.3M
315.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
$8,973,982.00
N/A
Revenue This Year
$12.64
N/A
Revenue Next Year
$8.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.99
N/A
52 Week Low
$0.22
$1.11
52 Week High
$1.07
$5.74

Technical Indicators

Market Signals
Indicator
MLSS
LTRN
Relative Strength Index (RSI) 60.23 45.48
Support Level $0.24 $1.11
Resistance Level $0.40 $2.41
Average True Range (ATR) 0.03 0.32
MACD 0.00 -0.03
Stochastic Oscillator 89.50 15.12

Price Performance

Historical Comparison
MLSS
LTRN

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: